NHS England gets commercialNHS England is no longer the new kid on the block, taking up its role in 2013. In Share XNHS England gets commercialhttps://deep-dive.pharmaphorum.com/magazine/access-and-commercialisation/nhs-england-commercial-framework-vpas/
Campaigners urge NHS to drop Roche acne drugCampaigners are demanding that the NHS stop prescribing Roche’s acne drug Roaccutane (isotretinoin), claiming it can lead to Share XCampaigners urge NHS to drop Roche acne drughttps://pharmaphorum.com/news/campaigners-urge-nhs-to-drop-roche-acne-drug/
Digital health entrepreneurs face NHS frustrationsHealth secretary Matt Hancock has made digital technology a priority for the NHS arguing that it could improve Share XDigital health entrepreneurs face NHS frustrationshttps://pharmaphorum.com/news/digital-health-entrepreneurs-face-nhs-frustrations/
VPAS 2024: What should industry consider next time?The UK pharmaceutical industry is just getting to grips with working under two new approaches to regulating branded Share XVPAS 2024: What should industry consider next time?https://pharmaphorum.com/views-analysis-market-access/vpas-2024-what-should-industry-consider-next-time/
NHS hospitals join with NVIDIA, using AI to interpret radiology scansGraphics card specialist NVIDIA and King’s College London have announced they are partnering to build an artificial intelligence Share XNHS hospitals join with NVIDIA, using AI to interpret radiology scanshttps://pharmaphorum.com/news/nhs-hospitals-join-with-nvidia-using-ai-to-interpret-radiology-scans/
Market access round-up: the UK opens up to innovationWhen it comes to market access in the UK, the public’s eye has mostly been on the ongoing Share XMarket access round-up: the UK opens up to innovationhttps://pharmaphorum.com/views-and-analysis/market-access-roundup-the-uk-opens-up-to-innovation/
Opening the digital door to the NHSThe UK government recently announced plans to open a ‘digital front door’ to the NHS by giving patients Share XOpening the digital door to the NHShttps://pharmaphorum.com/views-analysis-digital/opening-the-digital-door-to-the-nhs/
Shifting the paradigm from “disease care” to health careCat Oyler, vice president, global public health, tuberculosis at Johnson & Johnson, explains that by shifting focus to Share XShifting the paradigm from “disease care” to health carehttps://pharmaphorum.com/views-and-analysis/shifting-paradigm-disease-care-health-care/
UK pharma negotiating choppy seas during Brexit, says ABPI’s outgoing president Nordkamppharmaphorum caught up with Erik Nordkamp, outgoing president of the Association of the British Pharmaceutical Industry (ABPI), who Share XUK pharma negotiating choppy seas during Brexit, says ABPI’s outgoing president Nordkamphttps://pharmaphorum.com/views-analysis-market-access/uk-pharma-negotiating-choppy-seas-during-brexit-says-abpis-outgoing-president-nordkamp/
